Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2832)
All Articles published online
|
Sep 7, 2006 (publication date) through Jun 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fargion S, Borzio M, Maraschi A, Cargnel A, Lombardo TPOTGE. Triple antiviral therapy in HCV positive patients who failed prior combination therapy. World J Gastroenterol 2006; 12(33): 5293-5300 [PMID: 16981257 DOI: 10.3748/wjg.v12.i33.5293] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i33/5293.htm |
| Number | Citing Articles |
| 1 |
P. LANGLET, F. D’HEYGERE, J. HENRION, M. ADLER, J. DELWAIDE, H. VAN VLIERBERGHE, J. P. MULKAY, L. LASSER, R. BRENARD, Y. HORSMANS, P. MICHIELSEN, A. LAUREYS, F. NEVENS. Clinical trial: a randomized trial of pegylated‐interferon‐α‐2a plus ribavirin with or without amantadine in treatment‐naïve or relapsing chronic hepatitis C patients. Alimentary Pharmacology & Therapeutics 2009; 30(4): 352 doi: 10.1111/j.1365-2036.2009.04052.x
|
| 2 |
Ronald L Koretz, Maria Pleguezuelo, Vasiliki Arvaniti, Pilar Barrera Baena, Ruben Ciria, Kurinchi Selvan Gurusamy, Brian R Davidson, Andrew K Burroughs. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C. Cochrane Database of Systematic Reviews 2013; doi: 10.1002/14651858.CD003617.pub2
|
| 3 |
R. Chou, S. Carson, B. K. S. Chan. Pegylated interferons for chronic hepatitis C virus infection: an indirect analysis of randomized trials. Journal of Viral Hepatitis 2008; 15(8): 551 doi: 10.1111/j.1365-2893.2008.00984.x
|
| 4 |
A. G. Singal, A. K. Waljee, M. Shiffman, B. R. Bacon, P. S. Schoenfeld. Meta‐analysis: re‐treatment of genotype I hepatitis C nonresponders and relapsers after failing interferon and ribavirin combination therapy. Alimentary Pharmacology & Therapeutics 2010; 32(8): 969 doi: 10.1111/j.1365-2036.2010.04427.x
|